Home NDC 65219-080 Gadoterate Meglumine
Product NDC 65219-080
11-digit product format 652190080
Labeler code 65219
Product ID 65219-080_f05922b7-99d4-48c7-972a-7966bbbbc3b4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name gadoterate meglumine
Dosage form INJECTION
Route INTRAVENOUS
Labeler Fresenius Kabi USA, LLC
Application ANDA215304
Marketing category ANDA
Marketing start 2022-06-20
Substance GADOTERATE MEGLUMINE
Active strength 376.9 mg/mL
Pharmacologic classes Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215304-001 GADOTERATE MEGLUMINE GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 A215304-002 GADOTERATE MEGLUMINE GADOTERATE MEGLUMINE 3.769GM/10ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 A215304-003 GADOTERATE MEGLUMINE GADOTERATE MEGLUMINE 5.6535GM/15ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 A215304-004 GADOTERATE MEGLUMINE GADOTERATE MEGLUMINE 7.538GM/20ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 A215304-005 GADOTERATE MEGLUMINE GADOTERATE MEGLUMINE 37.69GM/100ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-15
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 149 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A215304-001 GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215304-002 GADOTERATE MEGLUMINE 3.769GM/10ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215304-003 GADOTERATE MEGLUMINE 5.6535GM/15ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215304-004 GADOTERATE MEGLUMINE 7.538GM/20ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 A215304-005 GADOTERATE MEGLUMINE 37.69GM/100ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-15 84e616aacf4f…2026-08-18 06:07:40 2026-07 A215304-001 GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215304-002 GADOTERATE MEGLUMINE 3.769GM/10ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215304-003 GADOTERATE MEGLUMINE 5.6535GM/15ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215304-004 GADOTERATE MEGLUMINE 7.538GM/20ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A215304-005 GADOTERATE MEGLUMINE 37.69GM/100ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A215304-001 GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215304-002 GADOTERATE MEGLUMINE 3.769GM/10ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215304-003 GADOTERATE MEGLUMINE 5.6535GM/15ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215304-004 GADOTERATE MEGLUMINE 7.538GM/20ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215304-005 GADOTERATE MEGLUMINE 37.69GM/100ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215304-001 GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215304-002 GADOTERATE MEGLUMINE 3.769GM/10ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215304-003 GADOTERATE MEGLUMINE 5.6535GM/15ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215304-004 GADOTERATE MEGLUMINE 7.538GM/20ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215304-005 GADOTERATE MEGLUMINE 37.69GM/100ML (376.9MG/ML) SOLUTION / INTRAVENOUS 2022-04-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A215304-001 GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215304-002 GADOTERATE MEGLUMINE 3.769GM/10ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215304-003 GADOTERATE MEGLUMINE 5.6535GM/15ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215304-004 GADOTERATE MEGLUMINE 7.538GM/20ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A215304-005 GADOTERATE MEGLUMINE 37.69GM/100ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215304-001 GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215304-002 GADOTERATE MEGLUMINE 3.769GM/10ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215304-003 GADOTERATE MEGLUMINE 5.6535GM/15ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215304-004 GADOTERATE MEGLUMINE 7.538GM/20ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215304-005 GADOTERATE MEGLUMINE 37.69GM/100ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215304-001 GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215304-002 GADOTERATE MEGLUMINE 3.769GM/10ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215304-003 GADOTERATE MEGLUMINE 5.6535GM/15ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215304-004 GADOTERATE MEGLUMINE 7.538GM/20ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215304-005 GADOTERATE MEGLUMINE 37.69GM/100ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215304-001 GADOTERATE MEGLUMINE 1.8845GM/5ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215304-002 GADOTERATE MEGLUMINE 3.769GM/10ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215304-003 GADOTERATE MEGLUMINE 5.6535GM/15ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215304-004 GADOTERATE MEGLUMINE 7.538GM/20ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215304-005 GADOTERATE MEGLUMINE 37.69GM/100ML (376.9MG/ML) SOLUTION / INTRAVENOUS AP 2022-04-15 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 124 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Gadoterate Meglumine
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength GADOTERATE MEGLUMINE 376.9 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination L0ND3981AG Internal UNII lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 65219-080-01 Gadoterate Meglumine 5 mL in 1 VIAL INJECTION 5 4 65219-080-01 Gadoterate Meglumine 1 in 1 CARTON INJECTION 1 4 65219-080-05 Gadoterate Meglumine 10 in 1 BOX INJECTION 10 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 65219-080 GADOTERATE MEGLUMINE INJECTION [FRESENIUS KABI USA, LLC] 3 Current NDC, Legacy NDC, 3 package rows 20240217_e0655aac-9508-4141-94f5-fcca6af1c41d.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 65219-080-01 65219008001 5 mL in 1 VIAL 5 ml Historical 65219-080-05 65219008005 10 CARTON in 1 BOX (65219-080-05) / 1 VIAL in 1 CARTON (65219-080-01) / 5 mL in 1 VIAL 10 carton 2022-06-20 0000-00-00 No No Current